Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-15 · accession 0001209191-23-049751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-18 | 2023-09-15 | PMVP | Alland Leila | Chief Medical Off | S - Sale | $6.62 | -6,291 | 45.9K | -12% | -$41.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | S | D | 6,291 | $6.62 | 45,909 | D | — | — |